An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...

Bio-Techne Corp. TECH has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference ...

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...

This valuable study identifies asymmetric dimethylarginine (ADMA) histones as potential determinants of the initial genomic binding of Rhino, a Drosophila-specific chromatin protein essential for ...

Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...

Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...

Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...

Bio-Techne (NASDAQ:TECH) signed a distribution agreement with the U.S. Pharmacopeia (USP) that allows the company to offer USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

The present study demonstrates that carbon nanoparticles (CNPs) can be used as labels in microarrays. CNPs were used in nucleic acid microarray immunoassays (NAMIAs) for the detection of different ...

As the immune response progresses, somatic mutation of antibody genes allows cells of higher affinity to arise and to be selected by antigen, accounting for affinity maturation.